David Shapiro, CMO and EVP - Development at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 1,350 shares at $128.66 ($174K) on 2017-03-01, disclosed to the SEC on 2017-03-03.
Open-market sale of $174k ICPT by CMO and EVP - Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |